Literature DB >> 16043747

Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study.

Maria Inês Schmidt1, Bruce B Duncan, Heejung Bang, James S Pankow, Christie M Ballantyne, Sherita H Golden, Aaron R Folsom, Lloyd E Chambless.   

Abstract

OBJECTIVE: To develop and evaluate clinical rules to predict risk for diabetes in middle-aged adults. RESEARCH DESIGN AND METHODS: The Atherosclerosis Risk in Communities is a cohort study conducted from 1987-1989 to 1996-1998. We studied 7,915 participants 45-64 years of age, free of diabetes at baseline, and ascertained 1,292 incident cases of diabetes by clinical diagnosis or oral glucose tolerance testing.
RESULTS: We derived risk functions to predict diabetes using logistic regression in a random half of the sample. Rules based on these risk functions were evaluated in the other half. A risk function based on waist, height, hypertension, blood pressure, family history of diabetes, ethnicity, and age was performed similarly to one based on fasting glucose (area under the receiver-operating characteristic curve [AUC] 0.71 and 0.74, respectively; P = 0.2). Risk functions composed of the clinical variables plus fasting glucose (AUC 0.78) and additionally including triglycerides and HDL cholesterol (AUC 0.80) performed better (P < 0.001). Evaluation of scores based on the metabolic syndrome as defined by the National Cholesterol Education Program or with slight variations showed AUCs of 0.75 and 0.78, respectively. Rules based on all these approaches, while identifying 20-56% of the sample as screen positive, achieved sensitivities of 40-87% and specificities of 50-86%.
CONCLUSIONS: Rules derived from clinical information, alone or combined with simple laboratory measures, can characterize degrees of diabetes risk in middle-aged adults, permitting preventive actions of appropriate intensity. Rules based on the metabolic syndrome are reasonable alternatives to rules derived from risk functions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043747     DOI: 10.2337/diacare.28.8.2013

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  179 in total

Review 1.  Lifestyle interventions in preventing new type 2 diabetes in Asian populations.

Authors:  Pietro Amedeo Modesti; Giorgio Galanti; Piergiuseppe Cala'; Maria Calabrese
Journal:  Intern Emerg Med       Date:  2015-10-16       Impact factor: 3.397

2.  Plasma lipid levels predict dysglycemia in a biracial cohort of nondiabetic subjects: Potential mechanisms.

Authors:  Ibiye Owei; Nkiru Umekwe; Jim Wan; Samuel Dagogo-Jack
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-17

Review 3.  The emerging role of HDL in glucose metabolism.

Authors:  Brian G Drew; Kerry-Anne Rye; Stephen J Duffy; Philip Barter; Bronwyn A Kingwell
Journal:  Nat Rev Endocrinol       Date:  2012-01-24       Impact factor: 43.330

4.  Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Authors:  Jukka Montonen; Dagmar Drogan; Hans-Georg Joost; Heiner Boeing; Andreas Fritsche; Erwin Schleicher; Matthias B Schulze; Tobias Pischon
Journal:  Eur J Epidemiol       Date:  2010-12-28       Impact factor: 8.082

Review 5.  Prediabetes and cardiovascular risk in hypertensive patients.

Authors:  Julian Segura; Cecilia Roldán; Jose A García-Donaire; Luis M Ruilope
Journal:  Curr Hypertens Rep       Date:  2006-05       Impact factor: 5.369

6.  The lack of utility of circulating biomarkers of inflammation and endothelial dysfunction for type 2 diabetes risk prediction among postmenopausal women: the Women's Health Initiative Observational Study.

Authors:  Chun Chao; Yiqing Song; Nancy Cook; Chi-Hong Tseng; JoAnn E Manson; Charles Eaton; Karen L Margolis; Beatriz Rodriguez; Lawrence S Phillips; Lesley F Tinker; Simin Liu
Journal:  Arch Intern Med       Date:  2010-09-27

Review 7.  The potential of novel biomarkers to improve risk prediction of type 2 diabetes.

Authors:  Christian Herder; Bernd Kowall; Adam G Tabak; Wolfgang Rathmann
Journal:  Diabetologia       Date:  2014-01       Impact factor: 10.122

Review 8.  Unexplained reciprocal regulation of diabetes and lipoproteins.

Authors:  Sei Higuchi; M Concepción Izquierdo; Rebecca A Haeusler
Journal:  Curr Opin Lipidol       Date:  2018-06       Impact factor: 4.776

9.  Reduced mitochondrial DNA content in lymphocytes is associated with insulin resistance and inflammation in patients with impaired fasting glucose.

Authors:  Mohamad Hafizi Abu Bakar; Nany Hairunisa; Hasniza Zaman Huri
Journal:  Clin Exp Med       Date:  2018-03-17       Impact factor: 3.984

10.  The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts.

Authors:  Maarit A Laaksonen; Paul Knekt; Harri Rissanen; Tommi Härkänen; Esa Virtala; Jukka Marniemi; Arpo Aromaa; Markku Heliövaara; Antti Reunanen
Journal:  Eur J Epidemiol       Date:  2009-12-13       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.